Bain Capital Life Sciences Investors, LLC: GEV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Bain Capital Life Sciences Investors, LLC on GEV, newest first. How the timeline and the estimate are built.

Bain Capital Life Sciences Investors, LLC held 0 GEV shares at 2025-03-31 per its 13F-HR filed 2025-05-15.

the latest 13F is the newest step

period ended2025-03-31
13F 0 shares
Change vs previous 13F -417,869 shares
13F-HR 0001768111-25-000007 filed by Bain Capital Public Equity Management II, LLC
Filed 2025-05-15 (acceptance time not in the bulk data set), ingested 2026-10-07 18:25:06 UTC
- Bain Capital Public Equity Management II, LLC: 0 shares
- Bain Capital Public Equity, LP: 0 shares
Acceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
period ended2024-12-31
13F 417,869 shares
Change vs previous 13F +174,396 shares
5.91% of the 13F portfolio, value $137,449,650.
13F-HR 0001768111-25-000003 filed by Bain Capital Public Equity Management II, LLC
Filed 2025-02-14 (acceptance time not in the bulk data set), ingested 2026-10-07 18:25:55 UTC
- Bain Capital Public Equity Management II, LLC: 396,986 shares
- Bain Capital Public Equity, LP: 20,883 shares
Acceptance time not in the bulk data set (spec §4.2).
period ended2024-09-30
13F 243,473 shares
Change vs previous 13F not available
2.67% of the 13F portfolio, value $62,080,746.
13F-HR 0001768111-24-000010 filed by Bain Capital Public Equity Management II, LLC
Filed 2024-11-14 (acceptance time not in the bulk data set), ingested 2026-10-07 18:26:56 UTC
- Bain Capital Public Equity Management II, LLC: 218,050 shares
- Bain Capital Public Equity, LP: 25,423 shares
Acceptance time not in the bulk data set (spec §4.2).